Lyra Therapeutics
LYRA
#9896
Rank
A$18.84 M
Marketcap
$0.29
Share price
5.88%
Change (1 day)
-95.89%
Change (1 year)

Lyra Therapeutics (LYRA) - Cash on Hand

Cash on Hand as of September 2024 : A$82.58 Million

According to Lyra Therapeutics's latest financial reports the company has A$82.58 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Lyra Therapeutics - Cash on Hand chart (from 2019 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$0.14 B127.98%
2021-12-31A$63.1 M-34.95%
2020-12-31A$97 M592.49%
2019-12-31A$14 M-58.69%
2018-12-31A$33.9 M